Session Chair Profile
Randy Scott is co-founder, chairman and CEO of Invitae Corporation (NYSE: NVTA), a company focused on bringing comprehensive genetic information into routine medical practice to improve the quality of healthcare for billions of people by making genetic testing more affordable and accessible. Prior to starting Invitae, Dr. Scott founded Genomic Health (NASDAQ: GHDX) in 2000 and led the company as CEO for nine years with a focus on improving the quality of treatment decisions for patients with cancer. Dr. Scott has played a role in founding several successful biotech companies in addition to Genomic Health Inc., including Incyte (NASDAQ: INCY), a genomic information company. Dr. Scott, an author of more than 40 scientific publications, 20 patents, and recipient of numerous awards, holds a Bachelor of Science degree in Chemistry from Emporia State University and a Ph.D. in Biochemistry from the University of Kansas.
Session Abstract – PMWC 2017 Silicon Valley
Session Synopsis: Historically genetic testing has been restricted to affected families due to the high cost of DNA sequencing. As costs come down we now have the capability to provide comprehensive genetic testing as part of health and prevention programs based on personal utility. This session explores the value and pitfalls of genetic testing in the healthy population.